Nadolol and Cellulitis aggravated - a phase IV clinical study of FDA data

Summary:

Cellulitis aggravated is reported as a side effect among people who take Nadolol (nadolol), especially for people who are female, 50-59 old, also take Prednisone, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Cellulitis aggravated when taking Nadolol. It is created by eHealthMe based on reports of 4,096 people who have side effects when taking Nadolol from the FDA, and is updated regularly.

What is Nadolol?

Nadolol has active ingredients of nadolol. It is often used in high blood pressure. eHealthMe is studying from 4,476 Nadolol users. Check the latest studies of Nadolol.

What is Cellulitis aggravated?

Cellulitis aggravated (worst condition of inaction under skin) is found to be associated with 1,534 drugs and 617 conditions by eHealthMe. Check the latest studies of Cellulitis aggravated.

On Jul, 06, 2026

4,096 people reported to have side effects when taking Nadolol.
Among them, 70 people (1.71%) have Cellulitis aggravated.

Could Nadolol cause Cellulitis aggravated?

Among these 70 people:

What is the gender of people who have Cellulitis aggravated when taking Nadolol? *

female: 68.57 %
male: 31.43 %

What is the age of people who have Cellulitis aggravated when taking Nadolol? *

What are other drugs people take besides Nadolol? *

What are other side effects people have besides Cellulitis aggravated? *

Pain: 50 people, 71.43%
Joint Pain: 43 people, 61.43%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 41 people, 58.57%
Fatigue (feeling of tiredness): 41 people, 58.57%
Weight Increased: 40 people, 57.14%
Urinary Tract Infection: 37 people, 52.86%
Peripheral Swelling: 36 people, 51.43%
Blood Pressure Systolic Increased: 35 people, 50.00%
Weight Decreased: 35 people, 50.00%
Fall: 35 people, 50.00%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 33 people, 47.14%
High Blood Cholesterol: 12 people, 17.14%
Pain: 7 people, 10.00%
Asthma: 5 people, 7.14%
Psoriasis (immune-mediated disease that affects the skin): 4 people, 5.71%
Hepatitis C: 3 people, 4.29%
Immunodeficiency Common Variable: 3 people, 4.29%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 2.86%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 2.86%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 2.86%

* Approximation only. Some reports may have incomplete information.

Do you take Nadolol and have Cellulitis aggravated?

- Check whether Cellulitis aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nadolol:

Nadolol (4,476 reports)

Browse all side effects of Nadolol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cellulitis aggravated:

Cellulitis aggravated (1,534 drugs)

Browse all the conditions that are associated with Cellulitis aggravated:

Cellulitis aggravated (617 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nadolol (the active ingredients of Nadolol) and Nadolol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.